Understanding what Modified Citrus Pectin (MCP) Pectasol-C® is, how it interacts with galectin‑3 and cancer, what the research shows, and what patients should know about safety, interactions, and integrative oncology considerations.

What Is Modified Citrus Pectin?

Modified citrus pectin (MCP), Pectasol-C, is a form of pectin derived from the peel and pulp of citrus fruits. Unlike regular pectin—which is too large to be absorbed—MCP is processed into smaller, low‑molecular‑weight fragments that the body can absorb more easily.

MCP is rich in galactoside residues, which give it a unique ability to bind to certain proteins involved in cancer biology, especially galectin‑3.

Pectasol-C® is a brand of MCP. 

How MCP May Influence Cancer Biology

Much of MCP’s anticancer interest comes from its ability to bind and block galectin‑3, a protein involved in:

• Tumor growth[i]
• cell adhesion
• metastasis[ii]
• angiogenesis
• immune evasion
• apoptosis resistance

Galectin‑3 is overexpressed ...

The Anticancer Actions of IV Vitamin C: Mechanisms, Dosing, Safety Labs, and Integration with Oncology Care

Researched and written by Keith Bishop, Clinical Nutritionist, Cancer Coach, and Founder of Prevail Over Cancer™, and the Prevail Protocol™

High-dose intravenous vitamin C (IVC) has reemerged as a promising adjunctive therapy in integrative oncology. Modern research highlights its unique pharmacology, potential anticancer mechanisms, and its ability to support patients undergoing chemotherapy, radiation, and immunotherapy. This guide breaks down the science, dosing considerations, safety labs, and clinical integration—supported by peer-reviewed medical literature.

What Makes IV Vitamin C Different From Oral Vitamin C?

Oral vitamin C absorption is tightly limited by intestinal transporters, which cap blood levels even at high doses. In contrast, IV administration bypasses intestinal absorption and produces blood concentrations 100–500× higher than those required for a...